Search
for
Sort by
Research 31–60 of 239
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- New drugs under investigation for the treatment of alopecias
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Role of janus kinase inhibitors in the treatment of alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Current and future pharmacotherapy for alopecia areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Review of Promising Off-Label Use of Deucravacitinib
- Application of Baricitinib in Dermatology
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Advances in the mechanism and new therapies of alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review